BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3406182)

  • 1. Muscle flaps in the management of vascular grafts in contaminated wounds: an experimental study in dogs.
    Cruz NI; Canario QM
    Plast Reconstr Surg; 1988 Sep; 82(3):480-5. PubMed ID: 3406182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of muscle flaps in the treatment of prosthetic vascular graft infections.
    Dacey LJ; Miett TO; Huntsman WT; Colen LB; Schned AR; McDaniel MD
    J Surg Res; 1988 May; 44(5):566-72. PubMed ID: 3374120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic Transversely Hemisected Sartorius Flap for High-Risk Groin Dissections in Vascular Surgery-A Case Series.
    Schurman AM; Myint J; Gusev M; Mannoia K; Teruya TH
    Ann Vasc Surg; 2024 Aug; 105():282-286. PubMed ID: 38599490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early results with use of gracilis muscle flap coverage of infected groin wounds after vascular surgery.
    Morasch MD; Sam AD; Kibbe MR; Hijjawi J; Dumanian GA
    J Vasc Surg; 2004 Jun; 39(6):1277-83. PubMed ID: 15192569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Gracilis Muscle Flaps in the Management of Groin Complications after Arterial Bypass with Prosthetic Graft.
    Dua A; Rothenberg KA; Lavingia K; Ho VT; Rao C; Desai SS
    Ann Vasc Surg; 2018 Aug; 51():113-118. PubMed ID: 29660388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle-flap coverage for infected peripheral vascular prostheses.
    Meland NB; Arnold PG; Pairolero PC; Lovich SF
    Plast Reconstr Surg; 1994 Apr; 93(5):1005-11. PubMed ID: 8134457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanded microporous polytetrafluoroethylene (PTFE) grafts in contaminated wounds: experimental and clinical study.
    Shah PM; Ito K; Clauss RH; Babu SC; Reynolds BM; Stahl WM
    J Trauma; 1983 Dec; 23(12):1030-3. PubMed ID: 6361274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sartorius muscle flap: an important adjunct for complicated femoral wounds involving vascular grafts.
    Landry GJ; Carlson JR; Liem TK; Mitchell EL; Edwards JM; Moneta GL
    Am J Surg; 2009 May; 197(5):655-9; discussion 659. PubMed ID: 19321154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin glue-antibiotic suspension in the prevention of prosthetic graft infection.
    Ney AL; Kelly PH; Tsukayama DT; Bubrick MP
    J Trauma; 1990 Aug; 30(8):1000-5; discussion 1005-6. PubMed ID: 2201786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the lymphatic system in acute arterial prosthetic graft infections.
    Rubin JR; Malone JM; Goldstone J
    J Vasc Surg; 1985 Jan; 2(1):92-8. PubMed ID: 3880833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of a gram-negative and a gram-positive infection on autogenous and prosthetic grafts.
    Geary KJ; Tomkiewicz ZM; Harrison HN; Fiore WM; Geary JE; Green RM; DeWeese JA; Ouriel K
    J Vasc Surg; 1990 Feb; 11(2):339-45; discussion 346-7. PubMed ID: 2105400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rifampin and cefazolin as prophylactic agents. A comparison in an animal model of vascular graft infection.
    Rutledge R; Baker VV; Sherertz R; Johnson G
    Arch Surg; 1982 Sep; 117(9):1164-5. PubMed ID: 7115063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of silver sulfadiazine in the treatment of prosthetic arterial bypass graft infection.
    McDaniel MD; Schned AR; Beck JR
    Surg Gynecol Obstet; 1986 Feb; 162(2):169-73. PubMed ID: 3945895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic binding to polytetrafluoroethylene via glucosaminoglycan-keratin luminal coating.
    Sobinsky KR; Flanigan DP
    Surgery; 1986 Oct; 100(4):629-34. PubMed ID: 2429376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of superficial femoral artery (SFA) occlusion on the outcome of proximal sartorius muscle transposition flaps in vascular surgery patients.
    Töpel I; Betz T; Uhl C; Steinbauer MG
    J Vasc Surg; 2011 Apr; 53(4):1014-9. PubMed ID: 21277148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polytetrafluoroethylene versus autogenous vein grafts for vascular reconstruction in contaminated wounds.
    Stone KS; Walshaw R; Sugiyama GT; Dean RE; Dunstan RW
    Am J Surg; 1984 May; 147(5):692-5. PubMed ID: 6721049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rotational muscle flap closure for acute groin wound infections following vascular surgery.
    Illig KA; Alkon JE; Smith A; Rhodes JM; Keefer A; Doyle A; Serletti J; Shortell CK; Davies MG; Green RM
    Ann Vasc Surg; 2004 Nov; 18(6):661-8. PubMed ID: 15599623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of early (<30 day) vascular groin infections using vacuum-assisted closure alone without muscle flap coverage in a consecutive patient series.
    Dosluoglu HH; Loghmanee C; Lall P; Cherr GS; Harris LM; Dryjski ML
    J Vasc Surg; 2010 May; 51(5):1160-6. PubMed ID: 20356703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between externally stented and unstented PTFE vascular grafts.
    Dunn MM; Robinette DR; Peoples JB
    Am Surg; 1988 Jun; 54(6):324-5. PubMed ID: 3377324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTFE graft treated with silver norfloxacin (AgNF): drug retention and resistance to bacterial challenge.
    Shah PM; Modak S; Fox CL; Babu SC; Sampath L; Clauss RH; Stahl WM
    J Surg Res; 1987 Mar; 42(3):298-303. PubMed ID: 3546939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.